A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

Clinical trial NCT07189325 · RECRUITING

Trial details

NCT number: NCT07189325
Sponsor: University Hospital, Montpellier
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing-Remitting Multiple Sclerosis (RRMS)Anti-CD20 Therapy

Start date: 2026-06-15
Primary completion: 2031-06-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.